Phase 2 Multicenter Trial of Rucaparib and Nivolumab As Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients with Advanced Biliary Tract Cancer (BTC): BilT-02

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 1|浏览36
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要